1998
Clinical Value of Acute Rest Technetium-99m Tetrofosmin Tomographic Myocardial Perfusion Imaging in Patients With Acute Chest Pain and Nondiagnostic Electrocardiograms
Heller G, Stowers S, Hendel R, Herman S, Daher E, Ahlberg A, Baron J, de Leon C, Rizzo J, Wackers F. Clinical Value of Acute Rest Technetium-99m Tetrofosmin Tomographic Myocardial Perfusion Imaging in Patients With Acute Chest Pain and Nondiagnostic Electrocardiograms. Journal Of The American College Of Cardiology 1998, 31: 1011-1017. PMID: 9562001, DOI: 10.1016/s0735-1097(98)00057-6.Peer-Reviewed Original ResearchConceptsAcute myocardial infarctionTomographic myocardial perfusionMyocardial infarctionChest painNondiagnostic electrocardiogramEmergency departmentHospital periodHospital admissionRest technetiumTetrofosmin SPECTMyocardial perfusionLow cardiac event rateTetrofosmin single photon emissionMultiple logistic regression analysisAcute chest painCardiac event rateNormal SPECT imagesMean cost savingsUnnecessary hospital admissionsLogistic regression analysisSingle photon emissionSPECT imagesAbnormal SPECTCardiac eventsRest Tc
1997
Extracardiac activity complicates quantitative cardiac SPECT imaging using a simultaneous transmission-emission approach.
Heller EN, DeMan P, Liu YH, Dione DP, Zubal IG, Wackers FJ, Sinusas AJ. Extracardiac activity complicates quantitative cardiac SPECT imaging using a simultaneous transmission-emission approach. Journal Of Nuclear Medicine 1997, 38: 1882-90. PMID: 9430462.Peer-Reviewed Original ResearchImproved diagnostic accuracy of planar imaging with technetium 99m-labeled tetrofosmin compared with thallium-201 for the detection of coronary artery disease
Khattar R, Hendel R, Crawley J, Wackers F, Rigo P, Zaret B, Sridhara B, Lahiri A. Improved diagnostic accuracy of planar imaging with technetium 99m-labeled tetrofosmin compared with thallium-201 for the detection of coronary artery disease. Journal Of Nuclear Cardiology 1997, 4: 291-297. PMID: 9278875, DOI: 10.1016/s1071-3581(97)90106-9.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overCoronary DiseaseFemaleHumansMaleMiddle AgedOrganophosphorus CompoundsOrganotechnetium CompoundsRadionuclide ImagingThallium RadioisotopesConceptsCoronary artery diseaseROC curve analysisPrevious myocardial infarctionArtery diseaseCurve analysisMyocardial infarctionMulticenter phase III trialTechnetium 99m-labeled tetrofosminDiagnostic accuracySingle-vessel diseasePhase III trialsCharacteristic curve analysisMultivessel diseaseIII trialsCoronary arteriographyROC curve areaThallium-201TetrofosminDiagnostic testsDiseaseDiagnostic performanceCurve areaInfarctionReference standardPlanar imaging
1996
Quantitative comparison of planar and SPECT normal data files of thallium-201, technetium-99m-sestamibi, technetium-99m-tetrofosmin and technetium-99m-furifosmin.
Naruse H, Daher E, Sinusas A, Jain D, Natale D, Mattera J, Makuch R, Wackers FJ. Quantitative comparison of planar and SPECT normal data files of thallium-201, technetium-99m-sestamibi, technetium-99m-tetrofosmin and technetium-99m-furifosmin. Journal Of Nuclear Medicine 1996, 37: 1783-8. PMID: 8917175.Peer-Reviewed Original ResearchDiagnostic utility of tomographic myocardial perfusion imaging with technetium 99m furifosmin (Q12) compared with thallium 201: Results of a phase III multicenter trial
Hendel R, Verani M, Miller D, Wackers F, McMahon M, Cerqueira M, Botvinick E, Kvols L, Gerson M. Diagnostic utility of tomographic myocardial perfusion imaging with technetium 99m furifosmin (Q12) compared with thallium 201: Results of a phase III multicenter trial. Journal Of Nuclear Cardiology 1996, 3: 291-300. PMID: 8799247, DOI: 10.1016/s1071-3581(96)90088-4.Peer-Reviewed Original ResearchMeSH KeywordsCoronary DiseaseExercise TestFemaleFuransHeartHumansMaleMiddle AgedOrganotechnetium CompoundsRadionuclide ImagingThallium RadioisotopesConceptsMyocardial perfusion agentPerfusion agentMulticenter trialNormalcy ratePhase III multicenter trialCoronary artery diseaseTomographic myocardial perfusionMyocardial perfusion imagingPanel of readersNew myocardial perfusion agentNew perfusion tracerPeak exerciseArtery diseaseThallium scintigraphyPerfusion scintigraphyMyocardial scintigraphyExercise workloadStudy groupLaboratory alterationsMyocardial perfusionThallium-201Perfusion imagingDiagnostic utilityScintigraphyPerfusion studies
1995
Technetium-99m-nitroimidazole (BMS181321): a positive imaging agent for detecting myocardial ischemia.
Shi CQ, Sinusas AJ, Dione DP, Singer MJ, Young LH, Heller EN, Rinker BD, Wackers FJ, Zaret BL. Technetium-99m-nitroimidazole (BMS181321): a positive imaging agent for detecting myocardial ischemia. Journal Of Nuclear Medicine 1995, 36: 1078-86. PMID: 7769431.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsCoronary CirculationDogsHeartLactatesLactic AcidMyocardial IschemiaNitroimidazolesOrganotechnetium CompoundsOxygen ConsumptionTomography, Emission-Computed, Single-PhotonConceptsIschemic regionMyocardial ischemiaBlood flowEx vivo SPECTRegional myocardial blood flowPartial coronary occlusionMicrosphere blood flowMyocardial blood flowOpen-chest canine modelVivo SPECT imagesSPECT imagesVivo planarCentral ischemic regionCoronary occlusionDemand ischemiaBMS181321Technetium-99mIntravenous injectionLiver ratioMyocardial imagingCanine modelPositive imagingHepatic clearanceLiver activityArterial samplingMyocardial perfusion imaging with 99mTc tetrofosmin. Comparison to 201Tl imaging and coronary angiography in a phase III multicenter trial. Tetrofosmin International Trial Study Group.
Zaret B, Rigo P, Wackers F, Hendel R, Braat S, Iskandrian A, Sridhara B, Jain D, Itti R, Serafini A, Goris M, Lahiri A. Myocardial perfusion imaging with 99mTc tetrofosmin. Comparison to 201Tl imaging and coronary angiography in a phase III multicenter trial. Tetrofosmin International Trial Study Group. Circulation 1995, 91: 313-9. PMID: 7805233, DOI: 10.1161/01.cir.91.2.313.Peer-Reviewed Original ResearchConceptsCoronary artery diseaseArtery diseaseTetrofosmin imagingCoronary angiographyMyocardial perfusionTetrofosmin imagesHealthy subjectsPhase III multicenter trialConventional myocardial perfusionLower likelihoodCentral core laboratoryMyocardial perfusion abnormalitiesNew 99mTcPeak heart rateNegative predictive accuracyMyocardial perfusion imagingNew myocardial imaging agentPlanar 201TlMulticenter trialNormalcy rateCoronary angiogramDouble productPerfusion abnormalitiesMyocardial imaging agentRadiotracer injection
1994
Reduced variability of interpretation and improved image quality with a technetium 99m myocardial perfusion agent: Comparison of thallium 201 and technetium 99m-labeled tetrofosmin
Hendel R, Parker M, Wackers F, Rigo P, Lahiri A, Zaret B. Reduced variability of interpretation and improved image quality with a technetium 99m myocardial perfusion agent: Comparison of thallium 201 and technetium 99m-labeled tetrofosmin. Journal Of Nuclear Cardiology 1994, 1: 509-514. PMID: 9420744, DOI: 10.1007/bf02939973.Peer-Reviewed Original ResearchCoronary DiseaseHeartHumansOrganophosphorus CompoundsOrganotechnetium CompoundsRadionuclide ImagingThallium RadioisotopesTechnetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia.
Sinusas AJ, Shi Q, Saltzberg MT, Vitols P, Jain D, Wackers FJ, Zaret BL. Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia. Journal Of Nuclear Medicine 1994, 35: 664-71. PMID: 8151391.Peer-Reviewed Original ResearchMeSH KeywordsAdenosineAnimalsCoronary CirculationDogsHeartMyocardial IschemiaOrganophosphorus CompoundsOrganotechnetium CompoundsRadionuclide ImagingConceptsTechnetium-99mCanine modelPerfusion tracerMicrosphere flowCoronary artery occlusionInitial myocardial uptakeIntact canine modelOpen-chest dogsMyocardial perfusion imagingMyocardial blood flowDynamic planar imagingArtery occlusionPharmacological vasodilatationPharmacological stressMyocardial perfusion tracersMyocardial uptakeRadiotracer injectionBlood flowMyocardial perfusionPerfusion imagingArterial samplingMyocardial flowBackground activity ratioTetrofosminIschemiaThe maze of myocardial perfusion imaging protocols in 1994
Wackers F. The maze of myocardial perfusion imaging protocols in 1994. Journal Of Nuclear Cardiology 1994, 1: 180-188. PMID: 9420685, DOI: 10.1007/bf02984090.Peer-Reviewed Original ResearchMeSH KeywordsHeartHumansOrganophosphorus CompoundsOrganotechnetium CompoundsOximesRadionuclide ImagingTechnetium Tc 99m SestamibiThallium Radioisotopes
1993
Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol.
Jain D, Wackers FJ, Mattera J, McMahon M, Sinusas AJ, Zaret BL. Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol. Journal Of Nuclear Medicine 1993, 34: 1254-9. PMID: 8326381.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedCoronary DiseaseExercise TestFemaleHumansMaleMiddle AgedOrganophosphorus CompoundsOrganotechnetium CompoundsRadionuclide ImagingTime FactorsConceptsOrgan ratiosGastrointestinal tractRest imagesImaging protocolSymptom-limited treadmill exerciseDecay-corrected countsLeft anterior oblique viewStress imagesAnterior oblique viewPortion of liverOptimal imaging protocolMyocardial perfusion imaging agentPeak exerciseTreadmill exerciseClinical trialsTechnetium-99mRadiotracer injectionMyocardial perfusionTetrofosmin imagesGallbladderPhase IEntire heartLiverTractOblique viewAssessing myocardial reperfusion with technetium-99m-labeled myocardial perfusion agents: basic concepts and clinical applications.
Sinusas AJ, Wackers FJ. Assessing myocardial reperfusion with technetium-99m-labeled myocardial perfusion agents: basic concepts and clinical applications. American Journal Of Cardiac Imaging 1993, 7: 24-38. PMID: 10148381.Peer-Reviewed Original ResearchMeSH KeywordsHumansMyocardial InfarctionMyocardial ReperfusionOrganotechnetium CompoundsRadionuclide ImagingThrombolytic TherapyConceptsVessel patencyPerfusion agentManagement of patientsAcute myocardial infarctionAssessment of reperfusionClinical applicationAcute coronary reperfusionMyocardial perfusion agentThrombolytic eraCoronary reperfusionMyocardial reperfusionPotential clinical applicationsMyocardial salvageMyocardial infarctionNoninvasive evaluationReperfusionPatencyResidual viabilityThrombolysisPatientsUnique biological propertiesBiological propertiesReocclusionInfarctionPerfusion
1992
Technetium-99m sestamibi myocardial imaging at rest for assessment of myocardial infarction and first-pass ejection fraction
Boucher C, Wackers F, Zaret B, Mena I. Technetium-99m sestamibi myocardial imaging at rest for assessment of myocardial infarction and first-pass ejection fraction. The American Journal Of Cardiology 1992, 69: 22-27. PMID: 1530901, DOI: 10.1016/0002-9149(92)90670-t.Peer-Reviewed Original ResearchConceptsWall motion abnormalitiesFirst-pass ejection fractionEjection fractionQ-wave infarctsMotion abnormalitiesQ wavesAbnormal TcMyocardial infarctionSestamibi studiesFirst-pass imagingAbility of technetiumVentricular ejection fractionOccurrence of infarctionSestamibi myocardial perfusionPerfusion abnormalitiesWall motionRegional perfusionPosterior infarctsMyocardial perfusionMyocardial segmentsPatientsInfarctionSestamibi imagesProtocol IInfarcts
1990
Thrombolytic therapy for myocardial infarction: Assessment of efficacy by myocardial perfusion imaging with technetium-99m sestamibi
Wackers F. Thrombolytic therapy for myocardial infarction: Assessment of efficacy by myocardial perfusion imaging with technetium-99m sestamibi. The American Journal Of Cardiology 1990, 66: e36-e41. PMID: 2145744, DOI: 10.1016/0002-9149(90)90610-d.Peer-Reviewed Original ResearchConceptsRecombinant tissue-type plasminogen activatorThrombolytic therapyMyocardial infarctionFirst acute myocardial infarctionInfarct-related artery patencyInitial risk areaPersistent coronary occlusionAcute chest painAcute myocardial infarctionAssessment of efficacyFuture clinical researchImaging agentNew thrombolytic agentsTissue-type plasminogen activatorArtery patencyChest painInfarct arterySuccessful thrombolysisConventional therapyCoronary occlusionHypoperfused myocardiumThrombolytic agentsMyocardial perfusionPatientsEnd pointSerial changes in myocardial perfusion using tomographic technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging following reperfusion therapy of myocardial infarction.
Pellikka P, Behrenbeck T, Verani M, Mahmarian J, Wackers F, Gibbons R. Serial changes in myocardial perfusion using tomographic technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging following reperfusion therapy of myocardial infarction. Journal Of Nuclear Medicine 1990, 31: 1269-75. PMID: 2143527.Peer-Reviewed Original ResearchConceptsReperfusion therapyMyocardial infarctionTc-sestamibiAcute reperfusion therapyFirst myocardial infarctionSuccessful reperfusionTomographic myocardial perfusion imagesSerial changesHypoperfused myocardiumMean decreaseFinal studyMyocardial perfusionPatientsSignificant improvementMyocardial perfusion imagesSecond studyTherapyPerfusion imagesReperfusionInfarctionPerfusionFurther decreaseHrTomographic imagingImagingQuantitative analysis of planar technetium-99m-sestamibi myocardial perfusion images using modified background subtraction.
Koster K, Wackers F, Mattera J, Fetterman R. Quantitative analysis of planar technetium-99m-sestamibi myocardial perfusion images using modified background subtraction. Journal Of Nuclear Medicine 1990, 31: 1400-8. PMID: 2143529.Peer-Reviewed Original Research
1989
Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction.
Gibbons R, Verani M, Behrenbeck T, Pellikka P, O'Connor M, Mahmarian J, Chesebro J, Wackers F. Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Circulation 1989, 80: 1277-1286. PMID: 2530004, DOI: 10.1161/01.cir.80.5.1277.Peer-Reviewed Original ResearchConceptsAcute myocardial infarctionMyocardial infarctionThrombolytic therapyTc-sestamibiHypoperfused myocardiumMyocardial perfusionLeft ventricleIntravenous tissue-type plasminogen activatorRegional wall motion scoreIntravenous thrombolytic therapyWall motion scoreTime of administrationEffect of treatmentSingle photon emissionTissue-type plasminogen activatorEjection fractionAnterior infarctsHypoperfused regionsInferior infarctsSimilar injectionsIntravenous injectionMotion scoreInfarctionMyocardial areaInfarct segmentsSerial quantitative planar technetium-99m isonitrile imaging in acute myocardial infarction: Efficacy for noninvasive assessment of thrombolytic therapy
Wackers F, Gibbons R, Verani M, Kayden D, Pellikka P, Behrenbeck T, Mahmarian J, Zaret B. Serial quantitative planar technetium-99m isonitrile imaging in acute myocardial infarction: Efficacy for noninvasive assessment of thrombolytic therapy. Journal Of The American College Of Cardiology 1989, 14: 861-873. PMID: 2507612, DOI: 10.1016/0735-1097(89)90456-7.Peer-Reviewed Original ResearchConceptsRecombinant tissue-type plasminogen activatorAcute myocardial infarctionPatent infarct-related arteryInfarct-related arteryThallium-201 imagingThrombolytic therapyMyocardial infarctionPlanar technetiumMyocardial perfusionExercise thallium-201 imagingFirst acute myocardial infarctionInfarct-related artery patencyInitial risk areaPersistent coronary occlusionSuccess of reperfusionMyocardial blood flowNew myocardial perfusionTissue-type plasminogen activatorArtery patencyChest painCoronary occlusionRepeat imagingBlood flowInfarctionThallium-201